Severity
Low
FDA Drug recall · Reported July 1, 2015
Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.
Indiana Botanic Gardens, Inc recalled Dr Blue Pain Relieving Gel, (4.6% menthol), For temporary relief of minor aches and pains… - a low-severity action.
Dr Blue Pain Relieving Gel, (4.6% menthol), For temporary relief of minor aches and pains… was recalled by Indiana Botanic Gardens, Inc in July 1, 2015. Reason: Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active in…. Check the official notice for the remedy. Verify recall #D-1149-2015 with the FDA Drug before acting.
The recall
Indiana Botanic Gardens, Inc issued this low-severity FDA Drug recall-Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active in….
Sourced from official FDA Drug enforcement records. Verify recall #D-1149-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1149-2015) was formally reported on July 1, 2015, with the manufacturer initiating the action on June 4, 2015. It is classified under Low severity (Class III), with a current status of Terminated. Indiana Botanic Gardens, Inc is listed as the recalling firm, operating out of Hobart, IN. Federal records list the affected scope as a) 630 2 oz. Tubes, b) 859 5 oz. Jars.
The documented reason for this recall is: Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol. Distribution data in the federal record shows the product reached: Nationwide and Puerto Rico. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
a) 630 2 oz. Tubes, b) 859 5 oz. Jars
Related Recalls
6
5 from same agency
Dr Blue Pain Relieving Gel, (4.6% menthol), For temporary relief of minor aches and pains of muscles and joints, a) 2 oz. Tube, NDC 10578-035-05, b) 5 oz. Jar, NDC 10578-035-04, Manufactured by Indiana Botanic Gardens, Hobart, IN 46342
Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-1149-2015 |
| Date reported | July 1, 2015 |
| Date initiated | June 4, 2015 |
| Recalling firm | Indiana Botanic Gardens, Inc |
| Firm location | Hobart, IN |
| Affected scope | a) 630 2 oz. Tubes, b) 859 5 oz. Jars |
| Distribution | Nationwide and Puerto Rico |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported July 1, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.